INPPL1 and neoplasm: The tumor-suppressive role of SHIP2 was found by Taylor et al. who observed that exogenous overexpression of SHIP2 negatively regulated AKT signalling pathway and repressed cell cycle progression in U87-MG glioblastoma cells to the same extent as PTEN18.